Grown Rogue International (GRUSF) Non Operating Income (2011 - 2026)
Grown Rogue International (GRUSF) posted quarterly Non Operating Income of -$1.8 million for Q1 2026, down 186.21% year-over-year from $2.1 million in Q1 2025, and up 100.0% quarter-over-quarter from -$7349.3 billion in Q4 2025.
Grown Rogue International (GRUSF) Non Operating Income (2011 - 2026) Analysis & Trends
Grown Rogue International's Non Operating Income history runs 5 years deep, the most recent figure standing at -$1.8 million for Q1 2026.
- In Q1 2026, Non Operating Income fell 186.21% year-over-year to -$1.8 million; the TTM figure through Mar 2026 stood at -$4803.7 billion (down 140.47% YoY), while the FY2025 annual figure was $5.4 million, up 144.57% from the prior year.
- Non Operating Income for Q1 2026 stood at -$1.8 million, up from -$7349.3 billion in the prior quarter.
- The five-year high for Non Operating Income was $13256.2 billion in Q4 2024, with the low at -$7349.3 billion in Q4 2025.
- The 4-year median for Non Operating Income is -$194852.0 (2023), against an average of $642.5 billion.
- The sharpest annual moves came in 2024 and 2026: Non Operating Income jumped 2104792095.96% in 2024, then slumped 186.21% in 2026.
- Grown Rogue International's Non Operating Income stood at $629812.0 in 2023, then surged by 2104792095.96% to $13256.2 billion in 2024, then tumbled by 155.44% to -$7349.3 billion in 2025, then surged by 100.0% to -$1.8 million in 2026.
- Business Quant data shows GRUSF's Non Operating Income at -$1.8 million in Q1 2026, -$7349.3 billion in Q4 2025, and $2545.6 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Grown Rogue International | 114.97 Mn | 109.89 Mn | 5.37 Mn | -1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.45 Mn |
| Mar 31, 2026 | -1.80 Mn |
| Dec 31, 2025 | -7,349.32 Bn |
| Sep 30, 2025 | 2,545.62 Bn |
| Jun 30, 2025 | 2.54 Mn |
| Mar 31, 2025 | 2.08 Mn |
| Dec 31, 2024 | 13,256.23 Bn |
| Sep 30, 2024 | -1,385.07 Bn |
| Jun 30, 2024 | -7.15 Mn |
| Mar 31, 2024 | -4.72 Mn |
| Dec 31, 2023 | 629,812.00 |
| Apr 30, 2023 | -194,852.00 |
| Feb 28, 2011 | -84,234.48 |